Caption Health is a technology company.
Caption Health has raised $61.0M across 3 funding rounds.
Key people at Caption Health.
Caption Health has raised $61.0M in total across 3 funding rounds.
Key people at Caption Health.
Caption Health has raised $61.0M in total across 3 funding rounds.
Caption Health's investors include 305 Ventures, Arrive, Bling Capital, Bold Capital Partners, Curie.Bio, Alan Cohen, Founders Fund, Great Oaks Venture Capital, Khosla Ventures, LGF, Operator Partners, Recode Ventures.
Caption Health is a technology company specializing in AI-powered medical imaging solutions, primarily focused on ultrasound. Their flagship product, Caption AI, transforms standard ultrasound machines into intelligent imaging assistants by providing real-time guidance and automated interpretation. This enables healthcare professionals of varying expertise to capture high-quality ultrasound images and make accurate diagnoses, thereby improving accessibility, accuracy, and efficiency in medical imaging. Caption Health serves healthcare providers aiming to detect diseases early, especially cardiac conditions, addressing the challenge of ultrasound’s traditionally high skill barrier and variability in image quality. The company has demonstrated strong growth momentum, culminating in its acquisition by GE HealthCare, which expands its reach and innovation capabilities in healthcare technology[1][2][3][4][7].
Founded in 2013 by a team of entrepreneurs, engineers, and clinicians, Caption Health emerged from the vision to democratize ultrasound imaging through artificial intelligence. The founders recognized the difficulty and specialized training required to perform quality ultrasound exams and sought to leverage AI to guide users in real time, making ultrasound more accessible and reliable. Early traction came from developing FDA-authorized software (Caption Guidance) that assists users in capturing diagnostic-quality cardiac ultrasound images, a breakthrough that positioned the company as a leader in AI-driven medical imaging. Their regulatory strategy and iterative development process were pivotal in gaining FDA clearance and reimbursement designations, validating their technology’s clinical and commercial potential[1][5][7].
Caption Health rides the convergence of artificial intelligence and medical imaging, a trend driven by the need for earlier disease detection, improved diagnostic accuracy, and expanded access to care. The timing is critical as healthcare systems seek cost-effective, scalable solutions to address workforce shortages and variability in diagnostic quality. Market forces such as increasing chronic disease prevalence, regulatory support for AI in healthcare, and the push for precision medicine favor Caption Health’s growth. By enabling non-expert users to perform ultrasound exams, Caption Health influences the broader ecosystem by democratizing advanced diagnostics, reducing healthcare disparities, and accelerating the adoption of AI in clinical workflows[2][3][5].
Looking ahead, Caption Health is poised to expand its AI-driven imaging solutions beyond cardiac ultrasound into other diagnostic areas, leveraging its partnership with GE HealthCare to scale globally. Trends such as AI integration in point-of-care diagnostics, telemedicine, and personalized medicine will shape its trajectory. The company’s influence is likely to grow as it continues to lower barriers to high-quality imaging, enabling earlier disease detection and better patient outcomes worldwide. Caption Health’s journey from startup to a key player in medical AI exemplifies the transformative potential of combining deep clinical insight with cutting-edge technology[1][2][7].
Caption Health has raised $61.0M across 3 funding rounds. Most recently, it raised $53.0M Series B in July 2020.
